Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Eight weeks after liraglutide or human umbilical cord mesenchymal stem cell administration, FPG, HbA<sub>1c</sub> , glucagon, body weight, and pancreatic ASK1, JNK, and BAX mRNA and proteins were significantly decreased, and the levels of serum C-p, INS and GLP-1, ratio of insulin positive area, and Bcl-2 expression were significantly increased in three treatment groups compared with T2DM group (P<.05). 31411368 2020
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE KEY MESSAGES: JNK1 is a link between obesity/type 2 diabetes and cognitive loss Inhibition of JNK1 is neuroprotective JNK1 constitutes a therapeutic strategy for cognitive loss. 31797011 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE STZ/nicotinamide-induced T2DM increased the expression of mitogen-activated protein kinases (MAPKs: p38, ERK, JNK) and inflammatory p65 protein. 29475461 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Specifically, Ex-4 stimulated protein kinase A (PKA) and phosphoinositide 3-kinase (PI3K)/Akt signaling, increasing cGMP and AMPK levels, and decreasing GSK3β and JNK activation in T2D rat brains. 28573460 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 PosttranslationalModification disease BEFREE The inhibition of JNK-JIP1 interaction, which interferes JNK phosphorylation, becomes a potential target for drug development of type 2 diabetes. 29129046 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE SAPK-JNK pathway performs a significant role in the pathogenesis of type 2 diabetes. 29710525 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Chicory inulin ameliorates type 2 diabetes mellitus and suppresses JNK and MAPK pathways in vivo and in vitro. 28105758 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease RGD Increased phagocyte-like NADPH oxidase and ROS generation in type 2 diabetic ZDF rat and human islets: role of Rac1-JNK1/2 signaling pathway in mitochondrial dysregulation in the diabetic islet. 21911753 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes. 21694775 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE The aim of this study was to determine the relationship between single nucleotide polymorphisms (SNPs) of MAPK8 and type 2 diabetes (T2DM). 18036196 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Thus, the c-Jun N-terminal kinase pathway plays a central role in pathogenesis of type 2 diabetes and could be a potential target for diabetes therapy. 16607699 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE The association between SNPs of MAP4K5 and type 2 diabetes (T2DM) was investigated due to the known relationship of the JNK pathway with T2DM. 16699725 2006